• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫草素通过Ras/MAPK和PI3K/AKT信号通路对人肾癌细胞产生凋亡作用。

Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways.

作者信息

Király József, Szabó Erzsébet, Fodor Petra, Fejes Zsolt, Nagy Béla, Juhász Éva, Vass Anna, Choudhury Mahua, Kónya Gábor, Halmos Gábor, Szabó Zsuzsanna

机构信息

Department of Biopharmacy, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.

Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, 4032 Debrecen, Hungary.

出版信息

Molecules. 2023 Sep 20;28(18):6725. doi: 10.3390/molecules28186725.

DOI:10.3390/molecules28186725
PMID:37764501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10534756/
Abstract

(1) Background: Shikonin, the main ingredient in Chinese herbal medicine, is described as a novel angiogenesis inhibitor, and its anticancer effects have already been studied. Shikonin and its derivatives induce apoptosis and suppress metastasis, which further enhance the effectiveness of chemotherapy. However, their mechanism of function has not been completely elucidated on human renal cancer cells. (2) Methods: In our study, CAKI-2 and A-498 cells were treated with increasing concentrations (2.5-40 µM) of shikonin, when colony formation ability and cytotoxic activity were tested. The changes in the expression of the main targets of apoptotic pathways were measured by RT-qPCR and Western blot. The intracellular levels of miR-21 and miR-155 were quantified by RT-qPCR. (3) Results: Shikonin exerted a dose-dependent effect on the proliferation of the cell lines examined. In 5 µM concentration of shikonin in vitro elevated caspase-3 and -7 levels, the proteins of the Ras/MAPK and PI3K/AKT pathways were activated. However, no significant changes were detected in the miR-21 and miR-155 expressions. (4) Conclusions: Our findings indicated that shikonin causes apoptosis of renal cancer cells by activating the Ras/MAPK and PI3K/AKT pathways. These effects of shikonin on renal cancer cells may bear important potential therapeutic implications for the treatment of renal cancer.

摘要

(1)背景:紫草素是中药的主要成分,被描述为一种新型血管生成抑制剂,其抗癌作用已得到研究。紫草素及其衍生物可诱导细胞凋亡并抑制转移,从而进一步增强化疗效果。然而,它们在人肾癌细胞上的作用机制尚未完全阐明。(2)方法:在我们的研究中,用浓度递增(2.5 - 40 μM)的紫草素处理CAKI - 2和A - 498细胞,同时检测集落形成能力和细胞毒性活性。通过RT - qPCR和蛋白质免疫印迹法检测凋亡途径主要靶点表达的变化。通过RT - qPCR定量miR - 21和miR - 155的细胞内水平。(3)结果:紫草素对所检测的细胞系增殖具有剂量依赖性作用。在体外5 μM浓度的紫草素作用下,半胱天冬酶 - 3和 - 7水平升高,Ras/MAPK和PI3K/AKT途径的蛋白质被激活。然而,miR - 21和miR - 155的表达未检测到显著变化。(4)结论:我们的研究结果表明,紫草素通过激活Ras/MAPK和PI3K/AKT途径导致肾癌细胞凋亡。紫草素对肾癌细胞的这些作用可能对肾癌治疗具有重要的潜在治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/b3c23aa7d091/molecules-28-06725-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/2676cdfae354/molecules-28-06725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/334fbc42c41b/molecules-28-06725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/1931ba631399/molecules-28-06725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/f047db5d8bea/molecules-28-06725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/0b58503f9c8e/molecules-28-06725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/4f7663af0a1c/molecules-28-06725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/0f60d2708c95/molecules-28-06725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/e30d9f7cf126/molecules-28-06725-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/db9c261011f4/molecules-28-06725-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/3cf3e6fbc6f3/molecules-28-06725-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/d5bf33b19354/molecules-28-06725-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/b3c23aa7d091/molecules-28-06725-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/2676cdfae354/molecules-28-06725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/334fbc42c41b/molecules-28-06725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/1931ba631399/molecules-28-06725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/f047db5d8bea/molecules-28-06725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/0b58503f9c8e/molecules-28-06725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/4f7663af0a1c/molecules-28-06725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/0f60d2708c95/molecules-28-06725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/e30d9f7cf126/molecules-28-06725-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/db9c261011f4/molecules-28-06725-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/3cf3e6fbc6f3/molecules-28-06725-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/d5bf33b19354/molecules-28-06725-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ae9/10534756/b3c23aa7d091/molecules-28-06725-g012.jpg

相似文献

1
Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways.紫草素通过Ras/MAPK和PI3K/AKT信号通路对人肾癌细胞产生凋亡作用。
Molecules. 2023 Sep 20;28(18):6725. doi: 10.3390/molecules28186725.
2
Shikonin Alleviates Gentamicin-Induced Renal Injury in Rats by Targeting Renal Endocytosis, SIRT1/Nrf2/HO-1, TLR-4/NF-κB/MAPK, and PI3K/Akt Cascades.紫草素通过靶向肾脏内吞作用、SIRT1/Nrf2/HO-1、TLR-4/NF-κB/MAPK和PI3K/Akt信号通路减轻庆大霉素诱导的大鼠肾损伤。
Antibiotics (Basel). 2023 Apr 28;12(5):826. doi: 10.3390/antibiotics12050826.
3
Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation.紫草素衍生物通过死亡受体和 MAPK 调控诱导人软骨肉瘤细胞凋亡和细胞周期停滞。
BMC Cancer. 2022 Jul 12;22(1):758. doi: 10.1186/s12885-022-09857-x.
4
Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.紫草素通过AKT/mTOR和ROS/ERK1/2信号通路降低基质金属蛋白酶-2/-9的表达,从而抑制前列腺癌细胞转移。
Int Immunopharmacol. 2014 Aug;21(2):447-55. doi: 10.1016/j.intimp.2014.05.026. Epub 2014 Jun 3.
5
Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.紫草素诱导细胞凋亡需要活性氧介导的 Akt/ASK1/p38 信号级联激活和 p21(Cip1)下调。
Apoptosis. 2013 Jul;18(7):870-81. doi: 10.1007/s10495-013-0835-5.
6
Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.紫草素通过靶向磷酸化β-连环蛋白和磷酸化PI3K/Akt抑制人胶质母细胞瘤细胞的迁移和侵袭:一种传统中药抗胶质瘤疗效的潜在机制。
Int J Mol Sci. 2015 Oct 9;16(10):23823-48. doi: 10.3390/ijms161023823.
7
Bioactive Small Molecule Enhances Skin Burn Wound Healing and Hair Follicle Regeneration by Activating PI3K/AKT Signaling Pathway: A Preclinical Evaluation in Animal Model.生物活性小分子通过激活PI3K/AKT信号通路促进皮肤烧伤创面愈合和毛囊再生:动物模型的临床前评估
J Biomed Nanotechnol. 2022 Feb 1;18(2):463-473. doi: 10.1166/jbn.2022.3251.
8
Shikonin inhibits proliferation, migration, invasion and promotes apoptosis in NCI-N87 cells via inhibition of PI3K/AKT signal pathway.紫草素通过抑制 PI3K/AKT 信号通路抑制 NCI-N87 细胞的增殖、迁移、侵袭,促进凋亡。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2662-2669. doi: 10.1080/21691401.2019.1632870.
9
Shikonin Exerts Cytotoxic Effects in Human Colon Cancers by Inducing Apoptotic Cell Death via the Endoplasmic Reticulum and Mitochondria-Mediated Pathways.紫草素通过内质网和线粒体介导的途径诱导凋亡性细胞死亡,从而对人类结肠癌发挥细胞毒性作用。
Biomol Ther (Seoul). 2019 Jan 1;27(1):41-47. doi: 10.4062/biomolther.2018.047.
10
The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.PTEN/PI3K/AKT信号通路在紫草素诱导慢性髓性白血病细胞凋亡及增殖抑制中的关键作用
Cell Physiol Biochem. 2018;47(3):981-993. doi: 10.1159/000490142. Epub 2018 May 24.

引用本文的文献

1
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies.线粒体自噬对癌症和神经退行性疾病的影响:对未来治疗的启示
J Hematol Oncol. 2025 Aug 1;18(1):78. doi: 10.1186/s13045-025-01727-w.
2
Shikonin a potent phytotherapeutic: a comprehensive review on metabolic reprogramming to overcome drug resistance in cancer.紫草素——一种有效的植物疗法:关于代谢重编程以克服癌症耐药性的全面综述
Mol Biol Rep. 2025 Mar 29;52(1):347. doi: 10.1007/s11033-025-10459-6.
3
Investigating the Role of Shikonin in Enhancing Osteogenesis and Angiogenesis for the Treatment of Osteoporosis.

本文引用的文献

1
Downregulation of miR-21 as a promising strategy to overcome drug resistance in cancer.下调 miR-21 作为克服癌症耐药性的有前途的策略。
Eur J Pharmacol. 2022 Oct 15;932:175233. doi: 10.1016/j.ejphar.2022.175233. Epub 2022 Aug 26.
2
Review of Shikonin and Derivatives: Isolation, Chemistry, Biosynthesis, Pharmacology and Toxicology.紫草素及其衍生物综述:分离、化学、生物合成、药理学与毒理学
Front Pharmacol. 2022 Jul 1;13:905755. doi: 10.3389/fphar.2022.905755. eCollection 2022.
3
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
研究紫草素在增强成骨作用和血管生成以治疗骨质疏松症中的作用。
ACS Omega. 2025 Feb 27;10(9):9718-9727. doi: 10.1021/acsomega.4c11161. eCollection 2025 Mar 11.
4
Renal cancer: signaling pathways and advances in targeted therapies.肾癌:信号通路与靶向治疗进展
MedComm (2020). 2024 Aug 1;5(8):e676. doi: 10.1002/mco2.676. eCollection 2024 Aug.
5
Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species.紫草素靶向活性氧的抗癌作用机制研究进展
Front Pharmacol. 2024 Jul 11;15:1416781. doi: 10.3389/fphar.2024.1416781. eCollection 2024.
6
The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.紫草素和 β,β-二甲基丙烯酰紫草素的细胞粘液纤维肉瘤肿瘤异质性模型的生物学评估。
Int J Mol Sci. 2023 Nov 2;24(21):15910. doi: 10.3390/ijms242115910.
肾细胞癌:流行病学、诊断和治疗概述。
G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3.
4
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway.紫草素通过激活坏死小体复合物并抑制AKT/mTOR信号通路来抑制舒尼替尼耐药性肾细胞癌的细胞生长。
Cancers (Basel). 2022 Feb 22;14(5):1114. doi: 10.3390/cancers14051114.
5
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.细胞凋亡失调与癌症多药耐药性的发展
Cancers (Basel). 2021 Aug 28;13(17):4363. doi: 10.3390/cancers13174363.
6
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis.紫草素主要通过坏死性凋亡降低多西他赛耐药前列腺癌细胞的生长。
Cancers (Basel). 2021 Feb 20;13(4):882. doi: 10.3390/cancers13040882.
7
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.miR-21作为癌症生物标志物的潜在作用及其在基于RNA的治疗中的重要性。
Mol Ther Nucleic Acids. 2020 Jun 5;20:409-420. doi: 10.1016/j.omtn.2020.03.003. Epub 2020 Mar 13.
8
Shikonin derivatives for cancer prevention and therapy.紫草素衍生物在癌症预防和治疗中的应用。
Cancer Lett. 2019 Sep 10;459:248-267. doi: 10.1016/j.canlet.2019.04.033. Epub 2019 May 24.
9
Shikonin-induced necroptosis in nasopharyngeal carcinoma cells via ROS overproduction and upregulation of RIPK1/RIPK3/MLKL expression.紫草素通过活性氧过量产生及RIPK1/RIPK3/MLKL表达上调诱导鼻咽癌细胞坏死性凋亡。
Onco Targets Ther. 2019 Apr 9;12:2605-2614. doi: 10.2147/OTT.S200740. eCollection 2019.
10
Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.紫草素通过糖原合酶激酶 3β 调控的β-连环蛋白信号抑制抑制作用逆转上皮间质转化,从而抑制三阴性乳腺癌细胞转移。
Biochem Pharmacol. 2019 Aug;166:33-45. doi: 10.1016/j.bcp.2019.05.001. Epub 2019 May 6.